RENAL CELL CARCINOMA RECURRENT

This adverse event was reported 127 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA RECURRENT:

# Drug Count
0 PEMBROLIZUMAB 35
1 NIVOLUMAB 16
2 CABOZANTINIB 15
3 LENVATINIB 12
4 PAZOPANIB HYDROCHLORIDE 11
5 AXITINIB 7
6 DEXAMETHASONE 6
7 DEXAMETHASONE 1.5 MG 6
8 EVEROLIMUS 6
9 MYCOPHENOLATE MOFETIL 6
See all common drugs associated with RENAL CELL CARCINOMA RECURRENT

RENAL CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PAZOPANIB HYDROCHLORIDE 11 0.0004
1 AXITINIB 7 0.0004
2 LENVATINIB 12 0.0004
3 PEMBROLIZUMAB 35 0.0003
4 CABOZANTINIB 15 0.0003
5 NIVOLUMAB 16 0.0002
6 EVEROLIMUS 6 0.0001
7 IPILIMUMAB 5 0.0001
8 ADALIMUMAB-FKJP 4 0.0001
9 ADALIMUMAB-AATY 4 0.0001
See all drugs enriched for association with RENAL CELL CARCINOMA RECURRENT